|
|||||
|
|
A novel long‐acting glucose‐dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents |
|
| Authors: | K. Tatarkiewicz D. M. Hargrove C. M. Jodka B. R. Gedulin P. A. Smith J. A. Hoyt A. Lwin L. Collins L. Mamedova O. E. Levy L. D'Souza S. Janssen V. Srivastava S. S. Ghosh D. G. Parkes |
| Affiliation: | Amylin Pharmaceuticals, LLC, , San Diego, CA, USA |
| Abstract: | |
| Keywords: | diabetes DPP‐IV resistant GIP rodents Trp‐cage |